Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwang-il Kim

Showing results (261-270 of 291) with videos related to

Pageof 30
Sort By:
Cancer Research|January 7, 2006
In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27Choon-Taek Lee, Yoon-Jin Lee, Sung-Youn Kwon, et al.
BMC Geriatrics|October 28, 2019
Impact of a delirium prevention project among older hospitalized patients who underwent orthopedic surgery: a retrospective cohort studyJung-Yeon Choi, Kwang-Il Kim, Min-Gu Kang, et al.
Cancer Letters|September 8, 2010
Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in gliomaSu Jin Jang, Joo Hyun Kang, Kwang Il Kim, et al.
Clinical Hypertension|November 1, 2023
Resistant hypertension: consensus document from the Korean society of hypertensionSungha Park, Jinho Shin, Sang Hyun Ihm, et al.
Clinical Hypertension|January 26, 2021
Smartphone / smartwatch-based cuffless blood pressure measurement : a position paper from the Korean Society of HypertensionHae Young Lee, Dong-Ju Lee, Jongmo Seo, et al.
JAMA|May 14, 2025
Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical TrialChan Joo Lee, Sang-Hyun Ihm, Dong-Ho Shin, et al.
Clinical Hypertension|December 1, 2022
A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapyEun-Seok Jeon, Sang Wook Lim, Seok-Yeon Kim, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 12, 2022
Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trialKi-Chul Sung, Jung Hoon Sung, Eun Joo Cho, et al.
Cancer Research and Treatment|March 14, 2025
Pilot Study for Feasibility of Onco-Geriatric Intervention Model in Older Patients with Cancer in a Tertiary Academic HospitalJin Won Kim, Jung-Yeon Choi, Woochan Park, et al.
Clinical Hypertension|August 31, 2023
Statement on chronotherapy for the treatment of hypertension: consensus document from the Korean society of hypertensionSungha Park, Sang-Hyun Ihm, In-Jeong Cho, et al.
Pageof 30

Showing results (261-270 of 291) with videos related to

Sort By:
Pageof 30
Cancer Research|January 7, 2006
In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27Choon-Taek Lee, Yoon-Jin Lee, Sung-Youn Kwon, et al.
BMC Geriatrics|October 28, 2019
Impact of a delirium prevention project among older hospitalized patients who underwent orthopedic surgery: a retrospective cohort studyJung-Yeon Choi, Kwang-Il Kim, Min-Gu Kang, et al.
Cancer Letters|September 8, 2010
Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in gliomaSu Jin Jang, Joo Hyun Kang, Kwang Il Kim, et al.
Clinical Hypertension|November 1, 2023
Resistant hypertension: consensus document from the Korean society of hypertensionSungha Park, Jinho Shin, Sang Hyun Ihm, et al.
Clinical Hypertension|January 26, 2021
Smartphone / smartwatch-based cuffless blood pressure measurement : a position paper from the Korean Society of HypertensionHae Young Lee, Dong-Ju Lee, Jongmo Seo, et al.
JAMA|May 14, 2025
Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical TrialChan Joo Lee, Sang-Hyun Ihm, Dong-Ho Shin, et al.
Clinical Hypertension|December 1, 2022
A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapyEun-Seok Jeon, Sang Wook Lim, Seok-Yeon Kim, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 12, 2022
Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trialKi-Chul Sung, Jung Hoon Sung, Eun Joo Cho, et al.
Cancer Research and Treatment|March 14, 2025
Pilot Study for Feasibility of Onco-Geriatric Intervention Model in Older Patients with Cancer in a Tertiary Academic HospitalJin Won Kim, Jung-Yeon Choi, Woochan Park, et al.
Clinical Hypertension|August 31, 2023
Statement on chronotherapy for the treatment of hypertension: consensus document from the Korean society of hypertensionSungha Park, Sang-Hyun Ihm, In-Jeong Cho, et al.
Pageof 30